LIXTE Biotechnology Holdings completed a corporate rebrand to NOMAD Power Solutions, Inc. on July 6, 2026, and began trading under the new Nasdaq ticker NMAD following its acquisition of NOMAD Transportable Power Systems, transitioning from cancer therapy development into AI energy infrastructure equipment and services.
Category: Stem, Inc.
A Nasdaq Company Just Reinvented Itself as a Power Company — and Bet It All on the AI Energy Crunch
LIXTE Biotechnology Holdings (NASDAQ: LIXT) entered into definitive documents on June 18, 2026, to combine with NOMAD Transportable Power Systems and rename itself NOMAD Power Solutions, deploying a $6.5 million pre-closing loan to NOMAD to fund component procurement and working capital as the company pivots entirely to deployable battery energy storage for data centers and utilities facing power constraints from AI infrastructure demand.
The AI Boom’s Real Bottleneck Is Power — and One Nasdaq Company Is Reinventing Itself to Solve It
LIXTE Biotechnology Holdings, Inc. (NASDAQ: LIXT) has entered into definitive documents to combine with NOMAD Transportable Power Systems and will rename itself NOMAD Power Solutions, Inc., repositioning as a pure-play deployable-power company; the company is funding NOMAD with a $6.5 million pre-closing loan ahead of the anticipated close on or about July 1, 2026.
The New Bottleneck Isn’t Computing Power — It’s Just Power
LIXTE Biotechnology Holdings, Inc. announced a definitive agreement to acquire NOMAD Transportable Power Systems, Inc., a deployable battery energy storage company, and intends to rename itself NOMAD Power Solutions upon closing to operate as a power availability platform addressing grid capacity constraints.